na
.
This transaction has concluded.
Premium Plan
| Established | Undisclosed |
| Employees | Undisclosed |
| Legal Entity | . |
| Reported Sales | Undisclosed |
| Run Rate Sales | Undisclosed |
| EBITDA Margin | Undisclosed |
| Industries | |
| Locations | |
| Local Time | 10:36 PM America / Los Angeles |
| Listed By | . |
| Status | Active |
None
USD
Undisclosed
Reason:
Business Overview
.
Products & Services Overview
.
Assets Overview
.
Facilities Overview
.
Capitalization Overview
.
Recent Activity
-
CEO, Curitiba, M&A Advisor connected with the Business
-
MD, Chennai, Financial Consultant connected with the Business
-
Manager, Istanbul, Financial Consultant connected with the Business
Tags:
Newly Established Specialty Pharmaceuticals Company Investment Opportunity in Los Angeles, United States
·Invest in Newly Established Specialty Pharmaceuticals Company in Los Angeles, United States
·Newly Established Specialty Pharmaceuticals Company Investment Opportunity in LA
·Newly Established Specialty Pharmaceuticals Company Investment Opportunity
·Invest in Newly Established Specialty Pharmaceuticals Company in LA
·Invest in Newly Established Specialty Pharmaceuticals Company
·Investment Opportunity in Los Angeles, United States
·Invest in Los Angeles, United States
·Investment Opportunity in LA
·Invest in LA
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
